Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
carmustine (bicnu) (1 trial)
o6-benzylguanine (1 trial)
Eye Neoplasms (Phase 3)
Glioblastoma (Phase 3)
Gliosarcoma (Phase 3)
Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (2 total)